Detalhe da pesquisa
1.
Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction.
Proc Natl Acad Sci U S A
; 120(1): e2209856120, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574653
2.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med
; 386(6): 556-567, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139274
3.
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial.
Breast Cancer Res Treat
; 204(2): 299-308, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175448
4.
Breast cancer during pregnancy-The oncologist's point of view.
Acta Obstet Gynecol Scand
; 103(4): 775-778, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37983830
5.
Pembrolizumab for Early Triple-Negative Breast Cancer.
N Engl J Med
; 382(9): 810-821, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101663
6.
Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records.
Breast Cancer Res Treat
; 198(3): 499-508, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856936
7.
Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression.
Cell
; 134(1): 62-73, 2008 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-18614011
8.
MNK2 governs the macrophage antiinflammatory phenotype.
Proc Natl Acad Sci U S A
; 117(44): 27556-27565, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077599
9.
Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study.
Breast Cancer Res Treat
; 194(1): 49-56, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461374
10.
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer.
Breast Cancer Res
; 23(1): 8, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33451345
11.
Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients.
Breast Cancer Res Treat
; 190(3): 451-462, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570302
12.
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.
Breast Cancer Res Treat
; 189(1): 15-23, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34218359
13.
Impairment of endoxifen formation in tamoxifen-treated premenopausal breast cancer patients carrying reduced-function CYP2D6 alleles.
Br J Clin Pharmacol
; 87(3): 1243-1252, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713032
14.
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trial.
Cancer
; 126(6): 1175-1182, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851385
15.
Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.
Oncologist
; 25(4): e709-e715, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297447
16.
The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma.
Oncologist
; 25(2): e321-e327, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043764
17.
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
N Engl J Med
; 377(19): 1836-1846, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29117498
18.
Chemotherapy use near the end-of-life in patients with metastatic breast cancer.
Breast Cancer Res Treat
; 181(3): 645-651, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383058
19.
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
Breast Cancer Res Treat
; 181(1): 87-96, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232698
20.
Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
Hum Reprod
; 35(4): 929-938, 2020 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32313940